Jacob Glanville
Jacob Glanville is the CEO and President of Centivax, a biotechnology company based in San Francisco. He is known for his work in the field of immunology and infectious diseases, focusing on the development of vaccines and therapeutic strategies. Glanville recently commented on the significance of Zoetis’ bird flu vaccine, emphasizing its potential to control avian influenza outbreaks and protect the agricultural economy, highlighting the urgent need for effective vaccination strategies in livestock.
Not in the pool (under ¢1).
Recent news mentions
Dr. Jacob Glanville, CEO of Centivax, a San Francisco biotechnology company, pointed out that the group that received more vaccines were older.
COVID vaccine linked to kidney injury, respiratory infections in studies
United States· 2025-11-20
Dr. Jacob Glanville emphasized that people should not use ChatGPT as a substitute for a doctor.
Man hospitalized after ChatGPT dietary advice leads to toxic poisoningUnited States· 2025-08-13
Dr. Jacob Glanville, CEO of Centivax, emphasized the importance of the study on mRNA vaccines.
New mRNA vaccine shows complete protection against deadly plague bacteriaUnited States· 2025-07-15
Jacob Glanville reached out to Tim Friede to collaborate on research involving snake venom immunity.
Por que este homem deixou que cobras venenosas o mordessem 200 vezes?
Liechtenstein· 2025-06-14
Jacob Glanville turned his attention towards antivenom and collaborated with Tim Friede on the research.
Snake-bite enthusiast spurs antivenom hope
Taiwan· 2025-06-09Jacob Glanville is an immunologist who contacted Tim Friede to collaborate on research related to snake venom immunity.
El hombre que se dejó morder por más de 200 serpientes - Ciencia
Paraguay· 2025-06-08Dr. Jacob Glanville said vaccines and most generic drugs would not likely be changed by the executive order.
America’s 10 priciest prescription medications by cost and by volumeUnited States· 2025-05-14
Jacob Glanville is the founder of a vaccine development company and collaborated with Freddy on the research.
جسمان مضادان في دم هذا الرجل قد يُسهمان في ابتكار مضاد جديد لسموم الثعابين
Saudi Arabia· 2025-05-11
Jacob Glanville recognized Tim Friede's unusual experiments and sought to develop a universal antivenom based on his immune response.
Zehirle gelen umut! Bilim insanlarını şaşırttı, 650’den fazla kez ısırıldı! ‘Yıllardır bunu bekliyordum, harika bir duygu’
Turkey· 2025-05-08
Jacob Glanville identified two antibodies in Friede's blood that can neutralize snake venom.
Index - Tudomány - Közel húsz éven át kígyókkal mérgezte magát, most életeket menthet a vére
Hungary· 2025-05-06Jacob Glanville is the lead study author and CEO of Centivax, who decided to study Tim Friede's blood for antivenom development.
Scientists create antivenom for snake bites using man’s bloodUnited States· 2025-05-05Jacob Glanville is the CEO of Centivax and is researching the potential of Tim Friede's blood as an antidote.
El hombre que se dejó morder más de 200 veces por serpientes venenosas (y cuya sangre sorprende a los científicos por su poder como antídoto)
Bolivia· 2025-05-05
Jacob Glanville explained the ethical concerns regarding the use of Friede's blood in the antivenom research.
Darah lelaki ‘kebal bisa’ bantu hasilkan penawar ular
Malaysia· 2025-05-05
Jacob Glanville is an immunologist who analyzed Tim Friede’s blood and is the CEO of biotech company Centivax.
The ‘air-dried chaplain’: Austrian mummy’s secrets revealed by new studyUnited States· 2025-05-04Jacob Glanville is the CEO of Centivax and is involved in researching Tim Friede's blood.
El hombre que se dejó morder más de 200 veces por serpientes venenosas (y cuya sangre sorprende a los científicos por su poder como antídoto)
Venezuela· 2025-05-04Jacob Glanville is an immunologist who contacted Tim Friede to request his blood for research on a universal antidote for snake bites.
Morso 202 volte dai suoi serpenti: Tim Friede ha donato il sangue alla scienza e ora c'è un antidoto nuovo
Italy· 2025-05-03Jacob Glanville is the CEO of Centivax and has collaborated with Tim Friede to develop a universal antivenom using antibodies from Friede's blood.
Người đàn ông tự tiêm nọc rắn độc để tìm thuốc giải
Vietnam· 2025-05-03
Jacob Glanville is the CEO of the California-based vaccine research company Centivax and led the study on the new antivenom.
El hombre que se dejó morder cientos de veces por serpientes venenosas abre el camino hacia un antídoto universal | Salud y bienestar
Spain· 2025-05-03
Immunologist Jacob Glanville came across media reports in 2017 of a man who had injected himself hundreds of times with the venom of some of the world’s deadliest snakes.
Man who injected himself with deadly venom helps create snakebite treatmentUnited States· 2025-05-03
Jacob Glanville is the chief executive of Centivax and the first author of the research on the antivenom.
Snake collector’s immunity quest opens path towards universal antivenom | Medical research
United Kingdom· 2025-05-02Dr. Jacob Glanville, CEO of Centivax, a San Francisco biotechnology company, echoed that the study has not yet undergone peer review.
Flu vaccine shown to increase infections in healthcare workers, with limitationsUnited States· 2025-04-10
Jacob Glanville, CEO and president of biotechnology company Centivax, noted that Zoetis’ bird flu vaccine is intended for veterinary use on bird flocks.
Bird flu vaccine gets ‘conditional license’ from USDA, company announcesUnited States· 2025-02-17